Document and Entity Information
Document and Entity Information | 6 Months Ended |
Feb. 28, 2022shares | |
Cover [Abstract] | |
Entity Registrant Name | Enertopia Corporation |
Entity Central Index Key | 0001346022 |
Document Period End Date | Feb. 28, 2022 |
Document Type | 10-Q |
Amendment Flag | false |
Document Quarterly Report | true |
Document Transition Report | false |
Entity File Number | 000-51866 |
Document Fiscal Period Focus | Q2 |
Document Fiscal Year Focus | 2022 |
Entity Incorporation, State or Country Code | NV |
Entity Tax Identification Number | 20-1970188 |
Entity Address, Address Line One | #18 1873 Spall Road |
Entity Address, City or Town | Kelowna |
Entity Address, Postal Zip Code | V1Y 4R2 |
City Area Code | 250 |
Local Phone Number | 870-2219 |
Entity Current Reporting Status | Yes |
Entity Common Stock, Shares Outstanding | 155,116,088 |
Entity Filer Category | Non-accelerated Filer |
Current Fiscal Year End Date | --08-31 |
Entity Small Business | true |
Entity Interactive Data Current | Yes |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Address, State or Province | BC |
UNAUDITED CONDENSED INTERIM BAL
UNAUDITED CONDENSED INTERIM BALANCE SHEETS - USD ($) | Feb. 28, 2022 | Aug. 31, 2021 |
Current | ||
Cash and cash equivalents | $ 131,199 | $ 354,286 |
Marketable securities | 0 | 14,994 |
Accounts receivable | 576 | 4,552 |
Prepaid expenses and deposit | 137,249 | 41,263 |
Total current assets | 269,024 | 415,095 |
Non-Current | ||
Mineral Property | 10,500 | 0 |
Total Assets | 279,524 | 415,095 |
Current | ||
Accounts payable | 274,716 | 309,277 |
Due to related parties | 85,409 | 111,659 |
Total Current Liabilities | 360,125 | 420,936 |
STOCKHOLDERS' EQUITY | ||
Share capital Authorized: 200,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 155,116,088 common shares at February 28, 2022 and August 31,2021: 139,211,700 | 155,117 | 139,213 |
Additional paid-in capital | 15,288,404 | 14,524,341 |
Deficit accumulated during the exploration stage | (15,524,122) | (14,669,395) |
Total Stockholders' Equity | (80,601) | (5,841) |
Total Liabilities and Stockholders' Equity | $ 279,524 | $ 415,095 |
UNAUDITED CONDENSED INTERIM B_2
UNAUDITED CONDENSED INTERIM BALANCE SHEETS (Parentheticals) - $ / shares | Feb. 28, 2021 | Aug. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, par value per share | $ 0.001 | $ 0.001 |
Common stock, shares outstanding | 155,116,088 | 139,211,700 |
CONDENSED INTERIM STATEMENTS OF
CONDENSED INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) | COMMON STOCK [Member] | ADDITIONAL PAID-IN CAPITAL [Member] | DEFICIT ACCUMULATED [Member] | Total |
Beginning Balance at Aug. 31, 2020 | $ 128,473 | $ 13,758,598 | $ (14,280,027) | $ (392,956) |
Beginning Balance (shares) at Aug. 31, 2020 | 128,471,700 | |||
Shares issued for LOI | 15,450 | 15,450 | ||
Comprehensive loss | 222,603 | 222,603 | ||
Ending Balance at Nov. 30, 2020 | $ 128,473 | 13,774,048 | (14,057,424) | (154,903) |
Ending Balance (shares) at Nov. 30, 2020 | 128,471,700 | |||
Beginning Balance at Aug. 31, 2020 | $ 128,473 | 13,758,598 | (14,280,027) | $ (392,956) |
Beginning Balance (shares) at Aug. 31, 2020 | 128,471,700 | |||
Stock options exercised (shares) | 2,720,000 | |||
Ending Balance at Feb. 28, 2021 | $ 136,233 | 14,365,172 | (14,352,649) | $ 148,756 |
Ending Balance (shares) at Feb. 28, 2021 | 136,231,700 | |||
Beginning Balance at Aug. 31, 2020 | $ 128,473 | 13,758,598 | (14,280,027) | $ (392,956) |
Beginning Balance (shares) at Aug. 31, 2020 | 128,471,700 | |||
Stock options exercised (shares) | 3,020,000 | |||
Warrants exercised (shares) | 2,720,000 | |||
Ending Balance at Aug. 31, 2021 | $ 139,213 | 14,524,341 | (14,669,395) | $ (5,841) |
Ending Balance (shares) at Aug. 31, 2021 | 139,211,700 | |||
Beginning Balance at Nov. 30, 2020 | $ 128,473 | 13,774,048 | (14,057,424) | (154,903) |
Beginning Balance (shares) at Nov. 30, 2020 | 128,471,700 | |||
Shares issued for patent (shares) | 2,000,000 | |||
Shares issued for patent | $ 2,000 | 67,000 | 69,000 | |
Private placement (shares) | 3,000,000 | |||
Private placement | $ 3,000 | 177,000 | 180,000 | |
Stock options exercised (shares) | 2,720,000 | |||
Stock options exercised | $ 2,720 | 72,328 | 75,048 | |
Warrants exercised (shares) | 40,000 | |||
Warrants exercised | $ 40 | 1,560 | 1,600 | |
Stock options granted | 273,236 | 273,236 | ||
Comprehensive loss | (295,225) | (295,225) | ||
Ending Balance at Feb. 28, 2021 | $ 136,233 | 14,365,172 | (14,352,649) | 148,756 |
Ending Balance (shares) at Feb. 28, 2021 | 136,231,700 | |||
Stock options exercised (shares) | 200,000 | |||
Stock options exercised | $ 200 | 13,800 | 14,000 | |
Stock options granted | 9,005 | 9,005 | ||
Comprehensive loss | (91,066) | (91,064) | ||
Ending Balance at May. 31, 2021 | $ 136,433 | 14,387,977 | (14,443,715) | 80,695 |
Ending Balance (shares) at May. 31, 2021 | 136,431,700 | |||
Stock options exercised (shares) | 100,000 | |||
Stock options exercised | $ 100 | 6,844 | ||
Warrants exercised (shares) | 2,680,000 | |||
Warrants exercised | $ 2,680 | 129,520 | ||
Comprehensive loss | (225,680) | (225,680) | ||
Ending Balance at Aug. 31, 2021 | $ 139,213 | 14,524,341 | (14,669,395) | (5,841) |
Ending Balance (shares) at Aug. 31, 2021 | 139,211,700 | |||
Stock options granted on Sept 1 | 23,056 | 23,056 | ||
Warrants exercised (shares) | 2,791,000 | |||
Warrants exercised | $ 2,791 | 128,599 | 131,390 | |
Comprehensive loss | (116,219) | (116,219) | ||
Ending Balance at Nov. 30, 2021 | $ 142,004 | 14,675,996 | (14,785,614) | 32,386 |
Ending Balance (shares) at Nov. 30, 2021 | 142,002,700 | |||
Beginning Balance at Aug. 31, 2021 | $ 139,213 | 14,524,341 | (14,669,395) | $ (5,841) |
Beginning Balance (shares) at Aug. 31, 2021 | 139,211,700 | |||
Stock options exercised (shares) | 113,388 | |||
Warrants exercised (shares) | 2,791,000 | |||
Ending Balance at Feb. 28, 2022 | $ 155,117 | 15,288,404 | (15,524,122) | $ (80,601) |
Ending Balance (shares) at Feb. 28, 2022 | 155,116,088 | |||
Beginning Balance at Nov. 30, 2021 | $ 142,004 | 14,675,996 | (14,785,614) | 32,386 |
Beginning Balance (shares) at Nov. 30, 2021 | 142,002,700 | |||
Shares issued for hydrogen technology (shares) | 2,000,000 | |||
Shares issued for hydrogen technology | $ 2,000 | 98,400 | 100,400 | |
Shares issued for investment in Joint Venture (shares) | 10,000,000 | |||
Shares issued for investment in Joint Venture | $ 10,000 | 440,000 | 450,000 | |
Shares issued for services | $ 1,000 | 41,300 | 42,300 | |
Shares issued for services (shares) | 1,000,000 | |||
Stock options exercised (shares) | 113,388 | |||
Stock options exercised | $ 113 | (113) | ||
Stock options granted | 32,821 | 32,821 | ||
Comprehensive loss | (738,508) | (738,508) | ||
Ending Balance at Feb. 28, 2022 | $ 155,117 | $ 15,288,404 | $ (15,524,122) | $ (80,601) |
Ending Balance (shares) at Feb. 28, 2022 | 155,116,088 |
CONDENSED INTERIM STATEMENTS _2
CONDENSED INTERIM STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Feb. 28, 2022 | Feb. 28, 2021 | Feb. 28, 2022 | Feb. 28, 2021 | |
Expenses | ||||
Accounting and audit | $ 9,795 | $ 11,026 | $ 12,465 | $ 16,261 |
Bank charges and interest expense | 602 | 329 | 1,066 | 554 |
Consulting | 57,593 | 10,500 | 91,629 | 13,500 |
Mineral exploration costs | 3,298 | 3,540 | 10,333 | 4,913 |
Fees and dues | 10,970 | 7,122 | 16,975 | 13,938 |
Investor relations | 8,608 | 11,427 | 20,356 | 15,674 |
Legal and professional | 6,478 | 7,252 | 26,062 | 11,165 |
Office and miscellaneous | 3,130 | 289 | 3,538 | 1,297 |
Research and development | 645,912 | 1,349 | 651,137 | 3,333 |
Rent | 2,593 | 1,722 | 5,224 | 1,722 |
Stock based compensation | 32,821 | 273,236 | 55,877 | 288,686 |
Telephone | 0 | 0 | 4,093 | 0 |
Total expenses | 781,800 | 327,792 | 898,755 | 371,043 |
Loss for the period before other items | (781,800) | (327,792) | (898,755) | (371,043) |
Other income (expense) | ||||
Foreign exchange gain (loss) | (1,329) | (1,040) | (1,042) | (2,330) |
Unrealized gain on marketable securities | 2,262 | 11,997 | 2,711 | 28,247 |
Gain on disposal of marketable securities | (7,641) | 21,610 | (7,641) | 22,504 |
Income from mineral property sale | 50,000 | 0 | 50,000 | 0 |
Income from royalty granted | 0 | 0 | 0 | 250,000 |
Net Income (loss) and comprehensive Income (loss) for the period | $ (738,508) | $ (295,225) | $ (854,727) | $ (72,622) |
Basic earnings (loss) per share | $ 0 | $ 0 | $ (0.01) | $ 0 |
Diluted earnings (loss) per share | $ 0 | $ 0 | $ (0.01) | $ 0 |
Weighted average number of common shares outstanding - basic | 151,986,777 | 132,405,922 | 146,780,966 | 130,427,943 |
Weighted average number of common shares outstanding - diluted | 151,986,777 | 132,405,922 | 146,780,966 | 130,427,943 |
CONDENSED INTERIM STATEMENTS _3
CONDENSED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) | 6 Months Ended | |
Feb. 28, 2022 | Feb. 28, 2021 | |
Cash flows used in operating activities | ||
Net Income (loss) | $ (854,727) | $ (72,622) |
Changes to reconcile net loss to net cash used in operating activities | ||
Shares issued for consulting | 42,300 | 0 |
Shares issued for purchase of hydrogen technology | 100,400 | 0 |
Shares issued for battery management technology | 450,000 | |
Stock based compensation | 55,877 | 288,686 |
Income from mineral property sale | (50,000) | (250,000) |
Unrealized gain on marketable securities | (2,711) | (28,247) |
Loss (gain) on disposal of marketable securities | 7,641 | (22,504) |
Change in non-cash working capital items: | ||
Accounts receivable | 3,976 | 483 |
Prepaid expenses and deposit | (95,986) | (38,930) |
Accounts payable and accrued liabilities | (34,561) | (15,826) |
Due to related parties | (26,250) | (28,875) |
Net cash (used in) operating activities | (404,041) | (167,835) |
Cash flows from Investing activities | ||
Proceeds from disposal of marketable securities | 10,064 | 31,905 |
Staking of mineral property | (10,500) | 0 |
Proceeds from mineral property sale | 50,000 | 0 |
Proceeds from royalty grant | 0 | 250,000 |
Net cash from investing activities | 49,564 | 281,905 |
Cash flows from (used in) Financing activities | ||
Net proceeds from options exercised | 0 | 75,048 |
Net proceeds from warrants exercised | 131,390 | 1,600 |
Net proceeds from subscriptions received | 0 | 180,000 |
Net cash from (used in) Financing activities | 131,390 | 256,648 |
Increase (Decrease) in cash and cash equivalents | (223,087) | 370,718 |
Cash and cash equivalents, beginning of period | 354,286 | 45,528 |
Cash and cash equivalents, end of period | 131,199 | 416,246 |
Supplemental information of cash flows | ||
Cashless option exercise | $ 113 | $ 0 |
ORGANIZATION
ORGANIZATION | 6 Months Ended |
Feb. 28, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION [Text Block] | 1. The unaudited condensed interim financial statements for the period ended February 28, 2022 included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These unaudited condensed interim financial statements should be read in conjunction with the August 31, 2021 audited annual financial statements and notes thereto. The Company was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. The Company was an independent natural resource company engaged in the exploration, development and acquisition of natural resources in the United States and Canada. In the fiscal year 2010, the Company shifted its strategic plan from its non-renewal energy operations to its planned renewal energy operations and natural resource acquisition and development. In late summer of 2013, the Company had another business sector in alternative health and wellness. During spring of 2016, the Company shifted its strategic plan to natural resource acquisitions and Lithium brine extraction technology. The Company office is located in Kelowna, B.C., Canada. |
GOING CONCERN UNCERTAINTY
GOING CONCERN UNCERTAINTY | 6 Months Ended |
Feb. 28, 2022 | |
Going Concern Uncertainty [Abstract] | |
GOING CONCERN UNCERTAINTY [Text Block] | 2. GOING CONCERN UNCERTAINTY The accompanying unaudited condensed interim financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business for the foreseeable future. The Company incurred net cash outflows from operating activities of $404,041 for the six months ended February 28, 2022 ($167,835 for the six months ended February 28, 2021) and as at February 28, 2022 has incurred cumulative losses of $15,524,122 that raises substantial doubt about its ability to continue as a going concern. Management has been able, thus far, to finance the operations through equity financing and cash on hand. There is no assurance that the Company will be able to continue to finance the Company on this basis. In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to obtain additional financing as may be required, to receive the continued support of the Company's shareholders, and ultimately to obtain successful operations. There are no assurances that we will be able to obtain further funds required for our continued operations. As noted herein, we are pursuing various financing alternatives to meet our immediate and long-term financial requirements. There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will be unable to conduct our operations as planned, and we will not be able to meet our other obligations as they become due. In such event, we will be forced to scale down or perhaps even cease our operations. There is significant uncertainty as to whether we can obtain additional financing. These unaudited condensed interim financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying unaudited condensed interim financial statements. Since March 2020, several measures have been implemented in Canada, the United States, and the rest of the world in response to the increased impact from the novel coronavirus ("COVID-19"). While the impact of COVID-19 is expected to be temporary, the current circumstances are dynamic and the impact on our business operations cannot be reasonably estimated at this time. We anticipate this could have an adverse impact on our exploration plans, results of operations, financial position and cash flows. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
Feb. 28, 2022 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES [Text Block] | 3. SIGNIFICANT ACCOUNTING POLICIES a) Basis of Presentation The accompanying unaudited condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and the instructions to Securities and Exchange Commission ("SEC") Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2021. b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions. |
MARKETABLE SECURITIES
MARKETABLE SECURITIES | 6 Months Ended |
Feb. 28, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
MARKETABLE SECURITIES [Text Block] | 4. MARKETABLE SECURITIES Marketable securities consist of the Company's investment in units of Grayscale Bitcoin Trust. As at February 28, 2022, the movement in the Company's marketable securities is as follows: Balance, August 31, 2020 24,354 Additions 17,705 Proceeds from disposals (21,385) Unrealized Gain (5,680) Balance, August 31, 2021 14,994 Unrealized gain 2,711 Proceeds from disposal (10,064) Loss on disposal (7,641) Balance, February 28, 2022 - |
MINERAL PROPERTY
MINERAL PROPERTY | 6 Months Ended |
Feb. 28, 2022 | |
Mineral Industries Disclosures [Abstract] | |
MINERAL PROPERTY [Text Block] | 5. MINERAL PROPERTY During the year ended August 30, 2017 the Company staked lode and placer claims on BLM lands in Esmerelda county Nevada covering approximately 160 Acres subject to adjustment. The Company has a 100% interest in the lands and is only responsible for the yearly maintenance fees to keep its 100% interest. The claims are in good standing until August 31, 2022. On October 28, 2019, the Company signed an LOI with Eagle Plains Resources Ltd. ("Eagle Plains") to earn up to 75% interest in the Pine Channel gold project in Saskatchewan, Canada (the "Pine Channel SK Property"). The terms of the LOI included periodic payments cash payments, exploration expenditures, as well as issuance of common shares of the Company. Upon signing the LOI, the Company issued 1,000,000 of its common shares to Eagle Plains, valued at $11,489. The Company dropped the LOI on Dec 13 th On February 11, 2020, the Company signed a 1% Royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $200,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party. On October 29, 2020, the Company signed a 1% Royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $250,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party. On February 24, 2022, the Company announced the proposed sale of the Lode and Placer claims of BLM lands in Esmeralda county Nevada covering approximately 160 Acres subject to adjustment to Cypress Development Corp. The Agreed upon selling price is $1,100,000 cash with $50,000 of this total being received on signing the definitive agreement and the issuance of 3,000,000 shares of Cypress Development Corp. This proposed sale is subject to Company shareholders approving the transaction at a special meeting to be held April 29, 2022 with a shareholder date of record being March 25th 2022, and other regulatory approvals. On February 25, 2022 the Company completed the staking of approximately 1,760 acres, covering 88 lode claims, prospective for Lithium Claystone in the Big Smoky Valley of western Nevada. Respective payments have been made to Esmeralda County and BLM for the year ending August 31, 2022. The Company owns 100% of the project, with no royalties payable. |
TECHNOLOGY DEVELOPMENT
TECHNOLOGY DEVELOPMENT | 6 Months Ended |
Feb. 28, 2022 | |
Technology Development [Abstract] | |
TECHNOLOGY DEVELOPMENT [Text Block] | 6. TECHNOLOGY DEVELOPMENT On December 6, 2021, The Company entered into a Definitive Purchase and Sale Agreement with Mr. Terry Galyon to acquire 100% ownership and rights to the Hydrogen Technology. The Company paid $25,000 in cash and issued 1,000,000 shares to Mr. Terry Galyon in consideration for acquiring the Hydrogen Technology. The Company has recorded the considerations for the purchase of the Hydrogen Technology as research and development expense in the condensed statement of operations for the period ended February 28, 2022, as follows: Consideration for Purchase of Hydrogen Technology Amount $ 2,000,000 shares at FV 0.0502 (Adjusted closing price on the date of the issuance) 100,400 Cash payment 25,000 Total 125,400 The technology is still in research and development phase and is not commercially feasible as at period ended February 28, 2022. The Company has incurred an additional $16,905 as research and development costs for the period ended February 28, 2022 related to hydrogen technology. |
BATTERY MANAGEMENT TECHNOLOGY
BATTERY MANAGEMENT TECHNOLOGY | 6 Months Ended |
Feb. 28, 2022 | |
Battery Management Technology [Abstract] | |
BATTERY MANAGEMENT TECHNOLOGY ("BMT") [Text Block] | 7. BATTERY MANAGEMENT TECHNOLOGY ("BMT") On December 17, 2021, The Company entered into a Definitive Purchase and Sale Agreement with Mr. Mark Snyder and Paul Sandler to acquire 100% ownership and rights to their Provisional Patent Pending BMT. The Company created a Joint Venture ("JV") with 51% controlling interest to run the commercial and industrial operations related to the BMT and has paid $30,000 in cash and issued 10,000,000 shares (5,000,000 shares of which are in escrow) valued at $450,000 for purchase of the BMT. BMT is still in research and development phase and have not obtained commercial or operational feasibility as at period ended February 28, 2022. The The Company has recorded the entire considerations of $480,000 for the ownership of the BMT as research and development expense in the condensed statement of operations for the period ended February 28, 2022. |
RELATED PARTIES TRANSACTION
RELATED PARTIES TRANSACTION | 6 Months Ended |
Feb. 28, 2022 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS [Text Block] | 8. RELATED PARTIES TRANSACTION For the six month period ended February 28, 2022, the Company was party to the following related party transactions: The Company incurred $ Nil Nil The amounts outstanding in accounts payable to the President of the Company as at February 28, 2022 is $85,409 (August 31, 2021 - $111,659). On December 6, 2021, the Company issued 250,000 stock options valued at $8,205 to the President of the Company (Note 10). The related party transactions are recorded at the exchange amount established and agreed to between the related parties. |
COMMON STOCK
COMMON STOCK | 6 Months Ended |
Feb. 28, 2022 | |
Stockholders' Equity Note [Abstract] | |
COMMON STOCK [Text Block] | 9. COMMON STOCK On December 14, 2020 the Company issued 1,000,000 common shares and an additional 1,000,000 common shares in escrow in connection with the signed Definitive Agreement (Note 6). On January 14, 2021 the Company closed the final tranche of a private placement of 3,000,000 units at a price of $0.06 per unit for gross proceeds of $180,000. Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance at a purchase price of $0.09. During the year ended August 31, 2021 the Company also issued 3,020,000 common shares as a result of the exercise of stock options and 2,720,000 common shares as a result of the exercise of warrants. During the six months ended February 28, 2022, the Company also issued 113,388 common shares as a result of the exercise of stock options and 2,791,000 common shares as a result of the exercise of warrants (Note10). On December 6, 2021 the Company issued 1,000,000 common shares and an additional 1,000,000 common shares in escrow in connection with the purchase of Hydrogen Technology (Note 6). On December 17, 2021 the Company issued 5,000,000 common shares and an additional 5,000,000 common shares in escrow in connection with the Investment in JV (Note 7). On February 25, 2022, the Company issued 1,000,000 shares to one consultant of the Company. As at February 28, 2022 and August 31, 2021 the Company had 155,116,088 (August 31, 2021: 139,211,700) shares issued and outstanding. |
STOCK OPTIONS AND WARRANTS
STOCK OPTIONS AND WARRANTS | 6 Months Ended |
Feb. 28, 2022 | |
Share-based Payment Arrangement [Abstract] | |
STOCK OPTIONS AND WARRANTS [Text Block] | 10. STOCK OPTIONS AND WARRANTS Stock Options On July 15, 2014, the shareholders approved and adopted at the Annual General Meeting the Company's 2014 Stock Option Plan. On April 14, 2011, the shareholders approved and adopted at the Annual General Meeting to consolidate the Company's 2007 Equity compensation plan and the Company's 2010 Equity Compensation Plan into a new Company 2011 Stock Option Plan. The purpose of these Plans is to advance the interests of the Corporation, through the grant of Options, by providing an incentive mechanism to foster the interest of eligible persons in the success of the Corporation and its affiliates; encouraging eligible persons to remain with the Corporation or its affiliates; and attracting new Directors, Officers, Employees and Consultants. On September 9, 2021, the Company issued 500,000 stock options to one of the consultants of the Company with an exercise price of $0.08 vested immediately, expiring September 9, 2026. On December 6, 2021, the Company issued 500,000 stock options to one of the consultants of the Company with an exercise price of $0.07 vested immediately, expiring December 6, 2026. On December 6, 2021, the Company issued 250,000 stock options to one of the consultants of the Company with an exercise price of $0.07 vested immediately, expiring December 6, 2026. On December 6, 2021, the Company issued 250,000 stock options to one director of the Company with an exercise price of $0.07 vested immediately, expiring December 6, 2026. The fair value of the options granted was estimated on the date of the grant using the Black-Scholes options pricing model, with the following weighted average assumptions: Expected dividend yield 0.00% Expected stock volatility 92% Risk-free interest rate 1.20% Expected life of options (years) 5.00 Expected forfeiture rate 0.00% Grant date fair value per option $0.06 During the six month period ended February 28, 2022, the Company recorded $55,877 (February 28, 2021 $288,686) as stock based compensation expenses. In addition, the Company issued 113,388 (February 28, 2021: 2,720,000) common shares of the Company as a result of exercise of 226,776 cashless stock options and a total of 2,950,000 stock options expired without being exercised (February 29, 2021: 1,100,000). A summary of the changes in stock options for the six months ended February 28, 2022 is presented below: Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2020 9,320,000 $ 0.06 Issued 5,150,000 0.10 Expired (1,100,000 ) 0.05 Exercised (3,293,224 ) 0.04 Balance, August 31, 2021 10,076,776 $ 0.08 Issued 1,500,000 0.10 Expired (2,950,000 ) 0.07 Exercised (226,776 ) 0.04 Balance, February 28, 2022 8,400,000 $ 0.08 The Company has the following options outstanding and exercisable: February 28, 2022 Issue Date Expiry Date Exercise Number of Remaining May 2, 2017 May 2, 2022 0.10 500,000 0.17 years October 27, 2017 October 27, 2022 0.05 800,000 0.66 years May 11, 2018 May 11, 2023 0.06 500,000 1.20 years May 22, 2018 May 22, 2023 0.07 450,000 1.23 years December 14, 2020 December 14, 2025 0.05 2,100,000 3.79 years January 28, 2021 January 28, 2026 0.14 2,000,000 3.92 years February 4, 2021 February 4, 2026 0.18 100,000 3.94 years February 5, 2021 February 5, 2026 0.18 300,000 3.94 years April 27, 2021 April 27, 2026 0.12 100,000 4.16 years May 28, 2021 May 28, 2026 0.12 50,000 4.25 years September 1, 2021 September 1, 2026 0.08 500,000 4.51 years December 6, 2021 December 6, 2026 0.07 1,000,000 4.77 years 0.09 8,400,000 3.19 years *As at February 28, 2022 the market price of the Company's common shares was $0.0423 per share. No incentive stock options were in the money. August 31, 2021 Issue Date Expiry Date Exercise Number of Remaining September 19, 2016 September 19, 2021 0.07 500,000 0.05 years January 20, 2017 January 20, 2022 0.07 1,200,000 0.39 years January 31, 2017 January 31, 2022 0.07 1,250,000 0.42 years May 2, 2017 May 2, 2022 0.10 500,000 0.67 years October 27, 2017 October 27, 2022 0.05 800,000* 1.16 years May 11, 2018 May 11, 2023 0.06 500,000* 1.69 years May 22, 2018 May 22, 2023 0.07 450,000 1.72 years February 25, 2020 February 25, 2022 0.02 226,776* 0.49 years December 14, 2020 December 14, 2025 0.05 2,100,000 4.29 years January 28, 2021 January 28, 2026 0.14 2,000,000 4.41 years February 4, 2021 February 4, 2026 0.18 100,000 4.43 years February 5, 2021 February 5, 2026 0.18 300,000 4.44 years April 27, 2021 April 27, 2026 0.12 100,000 4.66 years May 28, 2021 May 28, 2026 0.12 50,000 4.74 years 0.08 10,076,776 2.40 years *As at August 31, 2021 the market price of the Company's common shares was $0.0629 per share. A total of 3,626,776 incentive stock options were in the money with an intrinsic value of $48,589. Warrants During the period ended February 28, 2022 the Company extended 1,500,000 warrants attached to units in a private placement January 14 th A summary of warrants as at February 28, 2022 and August 31, 2021 is as follows: Weighted Average Number of warrants Exercise Price Balance, August 31, 2020 13,236,869 $ 0.05 Issued 1,500,000 0.09 Forfeited (2,300,000 ) 0.05 Exercised (2,720,000 ) 0.07 Balance, August 31, 2021 9,716,869 $ 0.05 Forfeited (452,500 ) 0.05 Exercised (2,791,000 ) 0.05 Balance, February 28, 2022 6,473,369 $ 0.05 The Company has the following warrants outstanding: February 28, 2022 Issue Date Expiry Date Exercise Number of March 27, 2019 March 27, 2023 0.04 4,973,369 January 14, 2021 May 14, 2022 0.09 1,500,000 0.05 6,473,369 *Each warrant entitles a holder to purchase one common share. |
COMMITMENTS
COMMITMENTS | 6 Months Ended |
Feb. 28, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS [Text Block] | 11. COMMITMENTS The Company has a consulting agreement with the President of the Company for corporate administration and consulting services for $3,500 per month plus goods and services tax ("GST") on a continuing basis. The President voluntarily suspended and terminated accrual of these consulting fees commencing on December 1, 2019 and continuing until such time as the Company's financial condition permits a resumption of such cost. |
SEGMENTED INFORMATION
SEGMENTED INFORMATION | 6 Months Ended |
Feb. 28, 2022 | |
Segment Reporting [Abstract] | |
SEGMENTED INFORMATION [Text Block] | 12. SEGMENTED INFORMATION As at February 28, 2022 and August 31, 2021, the Company is operating its business in one |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
Feb. 28, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation [Policy Text Block] | a) Basis of Presentation The accompanying unaudited condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and the instructions to Securities and Exchange Commission ("SEC") Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2021. |
Accounting Estimates [Policy Text Block] | b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions. |
MARKETABLE SECURITIES (Tables)
MARKETABLE SECURITIES (Tables) | 6 Months Ended |
Feb. 28, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of movement in marketable securities [Table Text Block] | Balance, August 31, 2020 24,354 Additions 17,705 Proceeds from disposals (21,385) Unrealized Gain (5,680) Balance, August 31, 2021 14,994 Unrealized gain 2,711 Proceeds from disposal (10,064) Loss on disposal (7,641) Balance, February 28, 2022 - |
TECHNOLOGY DEVELOPMENT (Tables)
TECHNOLOGY DEVELOPMENT (Tables) | 6 Months Ended |
Feb. 28, 2022 | |
Technology Development [Abstract] | |
Schedule of consideration for purchase of Hydrogen Technology [Table Text Block] | Consideration for Purchase of Hydrogen Technology Amount $ 2,000,000 shares at FV 0.0502 (Adjusted closing price on the date of the issuance) 100,400 Cash payment 25,000 Total 125,400 |
STOCK OPTIONS AND WARRANTS (Tab
STOCK OPTIONS AND WARRANTS (Tables) | 6 Months Ended |
Feb. 28, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | Expected dividend yield 0.00% Expected stock volatility 92% Risk-free interest rate 1.20% Expected life of options (years) 5.00 Expected forfeiture rate 0.00% Grant date fair value per option $0.06 |
Schedule Share-based Payment Arrangement, Option, Activity [Table Text Block] | Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2020 9,320,000 $ 0.06 Issued 5,150,000 0.10 Expired (1,100,000 ) 0.05 Exercised (3,293,224 ) 0.04 Balance, August 31, 2021 10,076,776 $ 0.08 Issued 1,500,000 0.10 Expired (2,950,000 ) 0.07 Exercised (226,776 ) 0.04 Balance, February 28, 2022 8,400,000 $ 0.08 |
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] | February 28, 2022 Issue Date Expiry Date Exercise Number of Remaining May 2, 2017 May 2, 2022 0.10 500,000 0.17 years October 27, 2017 October 27, 2022 0.05 800,000 0.66 years May 11, 2018 May 11, 2023 0.06 500,000 1.20 years May 22, 2018 May 22, 2023 0.07 450,000 1.23 years December 14, 2020 December 14, 2025 0.05 2,100,000 3.79 years January 28, 2021 January 28, 2026 0.14 2,000,000 3.92 years February 4, 2021 February 4, 2026 0.18 100,000 3.94 years February 5, 2021 February 5, 2026 0.18 300,000 3.94 years April 27, 2021 April 27, 2026 0.12 100,000 4.16 years May 28, 2021 May 28, 2026 0.12 50,000 4.25 years September 1, 2021 September 1, 2026 0.08 500,000 4.51 years December 6, 2021 December 6, 2026 0.07 1,000,000 4.77 years 0.09 8,400,000 3.19 years *As at February 28, 2022 the market price of the Company's common shares was $0.0423 per share. No incentive stock options were in the money. August 31, 2021 Issue Date Expiry Date Exercise Number of Remaining September 19, 2016 September 19, 2021 0.07 500,000 0.05 years January 20, 2017 January 20, 2022 0.07 1,200,000 0.39 years January 31, 2017 January 31, 2022 0.07 1,250,000 0.42 years May 2, 2017 May 2, 2022 0.10 500,000 0.67 years October 27, 2017 October 27, 2022 0.05 800,000* 1.16 years May 11, 2018 May 11, 2023 0.06 500,000* 1.69 years May 22, 2018 May 22, 2023 0.07 450,000 1.72 years February 25, 2020 February 25, 2022 0.02 226,776* 0.49 years December 14, 2020 December 14, 2025 0.05 2,100,000 4.29 years January 28, 2021 January 28, 2026 0.14 2,000,000 4.41 years February 4, 2021 February 4, 2026 0.18 100,000 4.43 years February 5, 2021 February 5, 2026 0.18 300,000 4.44 years April 27, 2021 April 27, 2026 0.12 100,000 4.66 years May 28, 2021 May 28, 2026 0.12 50,000 4.74 years 0.08 10,076,776 2.40 years *As at August 31, 2021 the market price of the Company's common shares was $0.0629 per share. A total of 3,626,776 incentive stock options were in the money with an intrinsic value of $48,589. |
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block] | Weighted Average Number of warrants Exercise Price Balance, August 31, 2020 13,236,869 $ 0.05 Issued 1,500,000 0.09 Forfeited (2,300,000 ) 0.05 Exercised (2,720,000 ) 0.07 Balance, August 31, 2021 9,716,869 $ 0.05 Forfeited (452,500 ) 0.05 Exercised (2,791,000 ) 0.05 Balance, February 28, 2022 6,473,369 $ 0.05 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | February 28, 2022 Issue Date Expiry Date Exercise Number of March 27, 2019 March 27, 2023 0.04 4,973,369 January 14, 2021 May 14, 2022 0.09 1,500,000 0.05 6,473,369 *Each warrant entitles a holder to purchase one common share. |
GOING CONCERN UNCERTAINTY (Narr
GOING CONCERN UNCERTAINTY (Narrative) (Details) - USD ($) | 6 Months Ended | ||
Feb. 28, 2022 | Feb. 28, 2021 | Aug. 31, 2021 | |
Going Concern Uncertainty [Abstract] | |||
Net cash (used in) operating activities | $ (404,041) | $ (167,835) | |
Cumulative losses | $ (15,524,122) | $ (14,669,395) |
MARKETABLE SECURITIES - Schedul
MARKETABLE SECURITIES - Schedule of movement in marketable securities (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Feb. 28, 2022 | Feb. 28, 2021 | Feb. 28, 2022 | Feb. 28, 2021 | Aug. 31, 2021 | |
Marketable Securities [Line Items] | |||||
Proceeds from disposals | $ (10,064) | $ (31,905) | |||
Loss on disposal | $ (7,641) | $ 21,610 | (7,641) | 22,504 | |
Unrealized Gain | 2,262 | $ 11,997 | 2,711 | 28,247 | |
Grayscale Bitcoin Trust [Member] | |||||
Marketable Securities [Line Items] | |||||
Beginning Balance | 14,994 | $ 24,354 | $ 24,354 | ||
Additions - cost | 17,705 | ||||
Proceeds from disposals | (10,064) | (21,385) | |||
Loss on disposal | (7,641) | ||||
Unrealized Gain | 2,711 | (5,680) | |||
Ending Balance | $ 0 | $ 0 | $ 14,994 |
MINERAL PROPERTY (Narrative) (D
MINERAL PROPERTY (Narrative) (Details) - USD ($) | Feb. 11, 2020 | Feb. 24, 2022 | Oct. 29, 2020 | Oct. 28, 2019 | Nov. 30, 2020 | Feb. 28, 2022 |
Mineral Industries [Line Items] | ||||||
Percentage of Land Rights Interest | 100.00% | |||||
Value of shares issued for LOI | $ 15,450 | |||||
Eagle Plains Resources Ltd [Member] | ||||||
Mineral Industries [Line Items] | ||||||
Percentage of letter of intent | 75.00% | |||||
Number of shares issued | 1,000,000 | |||||
Value of shares issued for LOI | $ 11,489 | |||||
Clayton Valley [Member] | ||||||
Mineral Industries [Line Items] | ||||||
Percentage of royalty agreement | 1.00% | 1.00% | ||||
Total selling price | $ 200,000 | $ 250,000 | ||||
Cypress Development Corp [Member] | ||||||
Mineral Industries [Line Items] | ||||||
Number of shares issued | 3,000,000 | |||||
Total selling price | $ 1,100,000 | |||||
Cash considaration | $ 50,000 |
TECHNOLOGY DEVELOPMENT (Narrati
TECHNOLOGY DEVELOPMENT (Narrative) (Details) - USD ($) | Dec. 06, 2021 | Feb. 28, 2022 | Feb. 28, 2021 | Feb. 28, 2022 | Feb. 28, 2021 |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Research and development costs | $ 645,912 | $ 1,349 | $ 651,137 | $ 3,333 | |
Hydrogen Technology [Member] | |||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Ownership percentage | 100.00% | ||||
Number of shares issued | 1,000,000 | 1,000,000 | |||
Cash payment | $ 25,000 | ||||
Research and development costs | $ 16,905 |
TECHNOLOGY DEVELOPMENT - Schedu
TECHNOLOGY DEVELOPMENT - Schedule of consideration for purchase of Hydrogen Technology (Details) | 3 Months Ended | 6 Months Ended |
Feb. 28, 2022USD ($)$ / shares | Feb. 28, 2022USD ($)$ / sharesshares | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Shares issued for hydrogen technology | $ 100,400 | |
Hydrogen Technology [Member] | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Shares issued for hydrogen technology | $ 100,400 | |
Cash payment | 25,000 | |
Total | $ 125,400 | $ 125,400 |
Stock price per share | $ / shares | $ 0.0502 | $ 0.0502 |
Shares issued for hydrogen technology (shares) | shares | 2,000,000 |
BATTERY MANAGEMENT TECHNOLOGY (
BATTERY MANAGEMENT TECHNOLOGY (Narrative) (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | ||
Dec. 17, 2021 | Feb. 28, 2022 | Feb. 28, 2021 | Feb. 28, 2022 | Feb. 28, 2021 | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Purchase value of BMT | $ 450,000 | ||||
Research and development expense | $ 645,912 | $ 1,349 | $ 651,137 | $ 3,333 | |
Battery Management Technology [Member] | |||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Research and development expense | $ 480,000 | ||||
Definitive Purchase and Sale Agreement [Member] | Mr. Mark Snyder and Paul Sandler [Member] | Battery Management Technology [Member] | |||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Equity ownership percentage | 100.00% | ||||
Cash | $ 30,000 | ||||
Number of common shares in escrow | 5,000,000 | ||||
Number of shares issued | 10,000,000 | ||||
Purchase value of BMT | $ 450,000 | ||||
Definitive Purchase and Sale Agreement [Member] | Mr. Mark Snyder and Paul Sandler [Member] | Battery Management Technology [Member] | Joint Venture [Member] | |||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Percentage of controlling interest | 51.00% |
RELATED PARTIES TRANSACTION (Na
RELATED PARTIES TRANSACTION (Narrative) (Details) - USD ($) | Dec. 06, 2021 | Feb. 28, 2022 | Feb. 28, 2022 | Feb. 28, 2021 | Aug. 31, 2021 |
Related Party Transaction [Line Items] | |||||
Due to the President | $ 85,409 | $ 85,409 | $ 111,659 | ||
Stock options granted (shares) | 1,500,000 | 5,150,000 | |||
Proceeds from stock option exercised | $ 0 | $ 75,048 | |||
President [Member] | |||||
Related Party Transaction [Line Items] | |||||
Due to the President | 85,409 | $ 85,409 | $ 111,659 | ||
Stock options granted (shares) | 250,000 | ||||
Proceeds from stock option exercised | $ 8,205 | ||||
Consulting fees |
COMMON STOCK (Narrative) (Detai
COMMON STOCK (Narrative) (Details) | Dec. 06, 2021shares | Jan. 14, 2021$ / shares | Jan. 14, 2021USD ($)shares | Dec. 14, 2020shares | Feb. 25, 2022shares | Dec. 17, 2021shares | Oct. 28, 2019shares | Feb. 28, 2022shares | Feb. 28, 2021shares | Aug. 31, 2021shares | Aug. 31, 2020shares |
Stockholders Equity Note [Line Items] | |||||||||||
Number of units issued in final tranche of private placement | 3,000,000 | ||||||||||
Units issue price at date of issuance | $ / shares | $ 0.06 | ||||||||||
Gross proceeds from issuance of units in final tranche of private placement | $ | $ 180,000 | ||||||||||
Description of units issuance in private placement | Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance at a purchase price of $0.09. | ||||||||||
Number of common shares issued in exercise of options | 113,388 | 2,720,000 | 3,020,000 | ||||||||
Number of common shares issued in exercise of warrants | 2,791,000 | 2,720,000 | |||||||||
Common Stock, Shares, Issued | 155,116,088 | 139,211,700 | |||||||||
Common Stock, Shares, Outstanding | 155,116,088 | 155,116,088 | 139,211,700 | 139,211,700 | |||||||
Hydrogen Technology [Member] | |||||||||||
Stockholders Equity Note [Line Items] | |||||||||||
Number of shares issued | 1,000,000 | 1,000,000 | |||||||||
Additional common shares in escrow | 1,000,000 | ||||||||||
Consultants 1 [Member] | |||||||||||
Stockholders Equity Note [Line Items] | |||||||||||
Number of shares issued | 1,000,000 | ||||||||||
Eagle Plains Resources Ltd [Member] | |||||||||||
Stockholders Equity Note [Line Items] | |||||||||||
Number of shares issued | 1,000,000 | ||||||||||
Definitive agreement [Member] | |||||||||||
Stockholders Equity Note [Line Items] | |||||||||||
Number of shares issued | 1,000,000 | 5,000,000 | |||||||||
Additional common shares in escrow | 1,000,000 | 5,000,000 |
STOCK OPTIONS AND WARRANTS (Nar
STOCK OPTIONS AND WARRANTS (Narrative) (Details) | Dec. 06, 2021$ / sharesshares | Sep. 09, 2021$ / sharesshares | Feb. 28, 2022USD ($)$ / shares | Feb. 28, 2021USD ($) | Feb. 28, 2022USD ($)$ / sharesshares | Feb. 28, 2021USD ($)shares | Aug. 31, 2021USD ($)$ / sharesshares |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Stock options granted (shares) | 1,500,000 | 5,150,000 | |||||
Stock options granted exercise price | $ / shares | $ 0.10 | $ 0.10 | |||||
Stock based compensation | $ | $ 32,821 | $ 273,236 | $ 55,877 | $ 288,686 | |||
Stock options exercised (shares) | 113,388 | 2,720,000 | 3,020,000 | ||||
Number of options, exercised | (226,776) | (3,293,224) | |||||
Number of warrants issued | 1,500,000 | 1,500,000 | |||||
Proceeds from stock option exercised | $ | $ 0 | $ 75,048 | |||||
Stock options expired | 2,950,000 | 1,100,000 | 1,100,000 | ||||
Market price of common shares | $ / shares | $ 0.0423 | $ 0.0423 | $ 0.0629 | ||||
Number of incentive stock options in the money | 3,626,776 | ||||||
Intrinsic value of stock options | $ | $ 48,589 | ||||||
Number of warrants exercised | 2,791,000 | 2,720,000 | |||||
Warrants exercised, exercise price | $ / shares | $ 0.05 | $ 0.07 | |||||
Number of warrants forfeited | 452,500 | 2,300,000 | |||||
Consultants 1 [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Stock options granted (shares) | 500,000 | 500,000 | |||||
Stock options granted exercise price | $ / shares | $ 0.07 | $ 0.08 | |||||
Consultant 2 [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Stock options granted (shares) | 250,000 | ||||||
Stock options granted exercise price | $ / shares | $ 0.07 | ||||||
Director [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Stock options granted (shares) | 250,000 | ||||||
Stock options granted exercise price | $ / shares | $ 0.07 |
STOCK OPTIONS AND WARRANTS - Sc
STOCK OPTIONS AND WARRANTS - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) | 6 Months Ended |
Feb. 28, 2022$ / shares | |
Share-based Payment Arrangement [Abstract] | |
Expected dividend yield | 0.00% |
Expected stock volatility | 92.00% |
Risk-free interest rate | 1.20% |
Expected life of options (years) | 5 years |
Expected forfeiture rate | 0.00% |
Grant date fair value per option | $ 0.06 |
STOCK OPTIONS AND WARRANTS - _2
STOCK OPTIONS AND WARRANTS - Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares | 6 Months Ended | 12 Months Ended | |
Feb. 28, 2022 | Feb. 28, 2021 | Aug. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |||
Number of options, beginning of period | 10,076,776 | 9,320,000 | 9,320,000 |
Options outstanding, weighted average exercise price, beginning of period | $ 0.08 | $ 0.06 | $ 0.06 |
Number of options, issued | 1,500,000 | 5,150,000 | |
Weighted average exercise price of options issued | $ 0.10 | $ 0.10 | |
Number of options, expired | (2,950,000) | (1,100,000) | (1,100,000) |
Weighted average exercise price of options expired | $ 0.07 | $ 0.05 | |
Number of options, exercised | (226,776) | (3,293,224) | |
Weighted average exercise price of options exercised | $ 0.04 | $ 0.04 | |
Number of options, end of period | 8,400,000 | 10,076,776 | |
Options outstanding, weighted average exercise price, end of period | $ 0.08 | $ 0.08 |
STOCK OPTIONS AND WARRANTS - Di
STOCK OPTIONS AND WARRANTS - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - $ / shares | 6 Months Ended | 12 Months Ended | |
Feb. 28, 2022 | Aug. 31, 2021 | Aug. 31, 2020 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Exercise prices | $ 0.08 | $ 0.08 | $ 0.06 |
Options outstanding and exercisable Number of shares | 8,400,000 | 10,076,776 | 9,320,000 |
Options outstanding and exercisable Remaining contractual life | 2 years 4 months 24 days | ||
September 19, 2016 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Sep. 19, 2016 | ||
Expiry Date | Sep. 19, 2021 | ||
Exercise prices | $ 0.07 | ||
Options outstanding and exercisable Number of shares | 500,000 | ||
Options outstanding and exercisable Remaining contractual life | 18 days | ||
January 20, 2017 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Jan. 20, 2017 | ||
Expiry Date | Jan. 20, 2022 | ||
Exercise prices | $ 0.07 | ||
Options outstanding and exercisable Number of shares | 1,200,000 | ||
Options outstanding and exercisable Remaining contractual life | 4 months 20 days | ||
January 31, 2017 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Jan. 31, 2017 | ||
Expiry Date | Jan. 31, 2022 | ||
Exercise prices | $ 0.07 | ||
Options outstanding and exercisable Number of shares | 1,250,000 | ||
Options outstanding and exercisable Remaining contractual life | 5 months 1 day | ||
May 2, 2017 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | May 2, 2017 | May 2, 2017 | |
Expiry Date | May 2, 2022 | May 2, 2022 | |
Exercise prices | $ 0.10 | $ 0.10 | |
Options outstanding and exercisable Number of shares | 500,000 | 500,000 | |
Options outstanding and exercisable Remaining contractual life | 2 months 1 day | 8 months 1 day | |
October 27, 2017 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Oct. 27, 2017 | Oct. 27, 2017 | |
Expiry Date | Oct. 27, 2022 | Oct. 27, 2022 | |
Exercise prices | $ 0.05 | $ 0.05 | |
Options outstanding and exercisable Number of shares | 800,000 | 800,000 | |
Options outstanding and exercisable Remaining contractual life | 7 months 28 days | 1 year 1 month 28 days | |
May 11, 2018 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | May 11, 2018 | May 11, 2018 | |
Expiry Date | May 11, 2023 | May 11, 2023 | |
Exercise prices | $ 0.06 | $ 0.06 | |
Options outstanding and exercisable Number of shares | 500,000 | 500,000 | |
Options outstanding and exercisable Remaining contractual life | 1 year 2 months 12 days | 1 year 8 months 8 days | |
May 22, 2018 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | May 22, 2018 | May 22, 2018 | |
Expiry Date | May 22, 2023 | May 22, 2023 | |
Exercise prices | $ 0.07 | $ 0.07 | |
Options outstanding and exercisable Number of shares | 450,000 | 450,000 | |
Options outstanding and exercisable Remaining contractual life | 1 year 2 months 23 days | 1 year 8 months 19 days | |
February 25, 2020 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Feb. 25, 2020 | ||
Expiry Date | Feb. 25, 2022 | ||
Exercise prices | $ 0.02 | ||
Options outstanding and exercisable Number of shares | 226,776 | ||
Options outstanding and exercisable Remaining contractual life | 5 months 26 days | ||
December 14, 2020 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Dec. 14, 2020 | Dec. 14, 2020 | |
Expiry Date | Dec. 14, 2025 | Dec. 14, 2025 | |
Exercise prices | $ 0.05 | $ 0.05 | |
Options outstanding and exercisable Number of shares | 2,100,000 | 2,100,000 | |
Options outstanding and exercisable Remaining contractual life | 3 years 9 months 14 days | 4 years 3 months 14 days | |
January 28, 2021 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Jan. 28, 2021 | Jan. 28, 2021 | |
Expiry Date | Jan. 28, 2026 | Jan. 28, 2026 | |
Exercise prices | $ 0.14 | $ 0.14 | |
Options outstanding and exercisable Number of shares | 2,000,000 | 2,000,000 | |
Options outstanding and exercisable Remaining contractual life | 3 years 11 months 1 day | 4 years 4 months 28 days | |
February 4, 2021 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Feb. 4, 2021 | Feb. 4, 2021 | |
Expiry Date | Feb. 4, 2026 | Feb. 4, 2026 | |
Exercise prices | $ 0.18 | $ 0.18 | |
Options outstanding and exercisable Number of shares | 100,000 | 100,000 | |
Options outstanding and exercisable Remaining contractual life | 3 years 11 months 8 days | 4 years 5 months 4 days | |
February 5, 2021 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Feb. 5, 2021 | Feb. 5, 2021 | |
Expiry Date | Feb. 5, 2026 | Feb. 5, 2026 | |
Exercise prices | $ 0.18 | $ 0.18 | |
Options outstanding and exercisable Number of shares | 300,000 | 300,000 | |
Options outstanding and exercisable Remaining contractual life | 3 years 11 months 8 days | 4 years 5 months 8 days | |
April 27, 2021 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Apr. 27, 2021 | Apr. 27, 2021 | |
Expiry Date | Apr. 27, 2026 | Apr. 27, 2026 | |
Exercise prices | $ 0.12 | $ 0.12 | |
Options outstanding and exercisable Number of shares | 100,000 | 100,000 | |
Options outstanding and exercisable Remaining contractual life | 4 years 1 month 28 days | 4 years 7 months 28 days | |
May 28, 2021 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | May 28, 2021 | May 28, 2021 | |
Expiry Date | May 28, 2026 | May 28, 2026 | |
Exercise prices | $ 0.12 | $ 0.12 | |
Options outstanding and exercisable Number of shares | 50,000 | 50,000 | |
Options outstanding and exercisable Remaining contractual life | 4 years 3 months | 4 years 8 months 26 days | |
September 01, 2021 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Sep. 1, 2021 | ||
Expiry Date | Sep. 1, 2026 | ||
Exercise prices | $ 0.08 | ||
Options outstanding and exercisable Number of shares | 500,000 | ||
Options outstanding and exercisable Remaining contractual life | 4 years 6 months 3 days | ||
December 6, 2021 [Member] | |||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |||
Issue Date | Dec. 6, 2021 | ||
Expiry Date | Dec. 6, 2026 | ||
Exercise prices | $ 0.07 | ||
Options outstanding and exercisable Number of shares | 1,000,000 | ||
Options outstanding and exercisable Remaining contractual life | 4 years 9 months 7 days |
STOCK OPTIONS AND WARRANTS - _3
STOCK OPTIONS AND WARRANTS - Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) - $ / shares | 6 Months Ended | 12 Months Ended |
Feb. 28, 2022 | Aug. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | ||
Number of warrants, Outstanding, Beginning of Period | 9,716,869 | 13,236,869 |
Weighted Average Exercise Price, Outstanding, Beginning of Period | $ 0.05 | $ 0.05 |
Number of warrants, Issued | 1,500,000 | 1,500,000 |
Weighted Average Exercise Price, Issued | $ 0.09 | |
Number of warrants, Forfeited | (452,500) | (2,300,000) |
Weighted Average Exercise Price, Forfeited | $ 0.05 | $ 0.05 |
Number of warrants, Exercised | (2,791,000) | (2,720,000) |
Weighted Average Exercise Price, Exercised | $ 0.05 | $ 0.07 |
Number of warrants, Outstanding, End of Period | 6,473,369 | 9,716,869 |
Weighted Average Exercise Price, Outstanding, End of Period | $ 0.05 | $ 0.05 |
STOCK OPTIONS AND WARRANTS - _4
STOCK OPTIONS AND WARRANTS - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - $ / shares | 6 Months Ended | ||
Feb. 28, 2022 | Aug. 31, 2021 | Aug. 31, 2020 | |
Class of Warrant or Right [Line Items] | |||
Exercise Price | $ 0.05 | ||
Number of Warrants | 6,473,369 | 9,716,869 | 13,236,869 |
March 27, 2019 [Member] | |||
Class of Warrant or Right [Line Items] | |||
Issue Date | Mar. 27, 2019 | ||
Expiry Date | Mar. 27, 2023 | ||
Exercise Price | $ 0.04 | ||
Number of Warrants | 4,973,369 | ||
January 14, 2021 [Member] | |||
Class of Warrant or Right [Line Items] | |||
Issue Date | Jan. 14, 2021 | ||
Expiry Date | May 14, 2022 | ||
Exercise Price | $ 0.09 | ||
Number of Warrants | 1,500,000 |
COMMITMENTS (Narrative) (Detail
COMMITMENTS (Narrative) (Details) | Feb. 28, 2022USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Corporate administration and consulting services per month plus goods and services tax | $ 3,500 |
SEGMENTED INFORMATION (Narrativ
SEGMENTED INFORMATION (Narrative) (Details) - Segment | 6 Months Ended | 12 Months Ended |
Feb. 28, 2022 | Aug. 31, 2021 | |
Segment Reporting [Abstract] | ||
Number of reportable segments | 1 | 1 |